Business

Hallucinations in AI: How GSK is addressing a critical problem in drug development

Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.

Jan 15, 2025 - 00:42
 0
Hallucinations in AI: How GSK is addressing a critical problem in drug development
VentureBeat/Ideogram
Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.Read More
Read More

Tags:

Previous Article

Experts Argue It’s Time for Obesity to Be Defined Beyond BMI

Next Article

Lunar Remastered Collection Physical Edition Is Exclusive To Amazon

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Insurers deny $19.7 million claim for fake Basquiat paintings seized by the FBI. Owners argue they should still pay for failing to verify authenticity

Insurers deny $19.7 million claim for fake Basquiat pai...

Jan 16, 2025  0

A Horrifying True Story, Told Through Mundane Details

A Horrifying True Story, Told Through Mundane Details

Jan 21, 2025  0

Gateway Funnel Pros Launches WooCommerce Payment Processing for Health and Wellness Entrepreneurs

Gateway Funnel Pros Launches WooCommerce Payment Proces...

Jan 19, 2025  0